SHORT TIME RESULT OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY ON ISCHEMIA DIABETIC FOOT ULCER

Hendry Irawan; Danny Zefanya Mooy; Ketut Putu Yasa

doi:10.22159/ajpcr.2018.v11i5.24759

Authors

Hendry Irawan Department of Surgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
Danny Zefanya Mooy Department of Surgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
Ketut Putu Yasa Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i5.24759

Keywords:

Ischemic diabetic foot ulcer, Percutaneous transluminal angioplasty, Rest pain

Abstract

Â The frequent complication of diabetes mellitus is ischemic diabetic foot ulcers (DFUs). As compared to non-diabetic people, ischemic of foot prevalence is significantly higher in diabetic people. It is related with severe clinical manifestations and the risk of critical limb ischemia and limb loss is increasing. In this case, we performed percutaneous transluminal angioplasty (PTA) in patient with ischemic DFU. A male, 58-year old, complained severe rest pain and gangrene in the fourth toe of the left foot more than 2 months. He had a history of diabetes mellitus type 2 for 4 years ago with uncontrolled blood sugar. We perform PTA to decrease the rest pain and prevent expand of the gangrene. The result of PTA was shown instant effect to reduce rest pain, pulses are easily palpable, and there was no expansion of the gangrene.

Downloads

Download data is not yet available.

Author Biography

Hendry Irawan, Department of Surgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia

Department of General Surgery

References

Gerassimidis T, Karkos CD, Karamanos D, Kamparoudis A. Current endovascular management of the ischaemic diabetic foot. Hippokratia 2008;12:67-73.

Hinchliffe RJ, Brownrigg JR, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev 2016;32:37-44.

Hinchliffe RJ, Andros G, Apelqvist J, Bakker K, Friederichs S, Lammer J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev 2012;28 Suppl 1:179-217.

Karri VV. Current perspective in the management of diabetic foot ulcers - An overview on the Indian scenario. Int J Pharm Pharm Sci 2014;6:1-2.

Thomas SM, Nitin IG, Reddy MU, Devi H. A prospective study: Knowledge assessment and patient care of diabetic foot ulcer patients in tertiary care hospital. Int J Pharm Pharm Sci 2017;9:104-10.

Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, et al. Extensive use of peripheral angioplasty, particularly in frapopliteal, in the treatment of ischaemic diabetic foot ulcers: Clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002;252:225-32.

Jacqueminet S, Hartemann-Heurtier A, Izzillo R, Cluzel P, Golmard JL, Ha Van G, et al. Percutaneous transluminal angioplasty in severe diabetic foot ischemia: Outcomes and prognostic factors. Diabetes Metab 2005;31:370-5.

Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: A new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007;33:453-60.

Reekers JA, Lammer J. Diabetic foot and PAD: The endovascular approach. Diabetes Metab Res Rev 2012;28:36-9.

Nasr MK, McCarthy RJ, Hardman J, Chalmers A, Horrocks M. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg 2002;23:398-403.

Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, et al. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg 2015:61:2S-41S.

Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg 2010;51:52S-68S.